These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 11561092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.
    Terry AV, Risbrough VB, Buccafusco JJ, Menzaghi F.
    J Pharmacol Exp Ther; 2002 Apr; 301(1):284-92. PubMed ID: 11907185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.
    Rao TS, Reid RT, Correa LD, Santori EM, Gardner MF, Sacaan AI, Lorrain D, Vernier JM.
    Brain Res; 2003 Oct 03; 986(1-2):71-81. PubMed ID: 12965231
    [Abstract] [Full Text] [Related]

  • 7. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
    Schneider JS, Tinker JP, Van Velson M, Menzaghi F, Lloyd GK.
    J Pharmacol Exp Ther; 1999 Aug 03; 290(2):731-9. PubMed ID: 10411585
    [Abstract] [Full Text] [Related]

  • 8. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.
    Decamp E, Schneider JS.
    Eur J Neurosci; 2006 Oct 03; 24(7):2098-104. PubMed ID: 17067307
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
    Decker MW, Bannon AW, Curzon P, Gunther KL, Brioni JD, Holladay MW, Lin NH, Li Y, Daanen JF, Buccafusco JJ, Prendergast MA, Jackson WJ, Arneric SP.
    J Pharmacol Exp Ther; 1997 Oct 03; 283(1):247-58. PubMed ID: 9336330
    [Abstract] [Full Text] [Related]

  • 12. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys.
    Buccafusco JJ, Terry AV, Decker MW, Gopalakrishnan M.
    Biochem Pharmacol; 2007 Oct 15; 74(8):1202-11. PubMed ID: 17706609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task.
    Grottick AJ, Wyler R, Higgins GA.
    Pharmacol Biochem Behav; 2001 Dec 15; 70(4):505-13. PubMed ID: 11796150
    [Abstract] [Full Text] [Related]

  • 15. Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.
    Decamp E, Schneider JS.
    Brain Res; 2009 Mar 25; 1262():109-14. PubMed ID: 19368843
    [Abstract] [Full Text] [Related]

  • 16. Nicotinic receptor subtypes and cognitive function.
    Levin ED.
    J Neurobiol; 2002 Dec 25; 53(4):633-40. PubMed ID: 12436426
    [Abstract] [Full Text] [Related]

  • 17. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul 25; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 18. Ultra-low exposure to α-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in α-7 receptor expression in rodents: implications for low dose clinical efficacy.
    Werkheiser JL, Sydserff S, Hubbs SJ, Ding M, Eisman MS, Perry D, Williams AJ, Smith JS, Mrzljak L, Maier DL.
    Neuroscience; 2011 Jul 14; 186():76-87. PubMed ID: 21550383
    [Abstract] [Full Text] [Related]

  • 19. Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys.
    Terry AV, Plagenhoef M, Callahan PM.
    Psychopharmacology (Berl); 2016 Mar 14; 233(5):761-71. PubMed ID: 26612616
    [Abstract] [Full Text] [Related]

  • 20. Strain-dependent effects of cognitive enhancers in the mouse.
    Sunyer B, Patil S, Frischer C, Hoeger H, Lubec G.
    Amino Acids; 2008 Apr 14; 34(3):485-95. PubMed ID: 17690951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.